US Patent 7495002 3-methyl-7-butinyl-xanthines, the preparation thereof and their use as pharmaceutical compositions

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7495002

Date of Patent

February 24, 2009

Patent Application Number

11218056

Date Filed

September 1, 2005

Patent Citations Received

‌

US Patent 12024522 Salts and processes of preparing a PI3K inhibitor

‌

US Patent 11911387 Vasoprotective and cardioprotective antidiabetic therapy

‌

US Patent 11919903 Polymorphs

‌

US Patent 11999751 Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors

‌

US Patent 11819505 Heterocyclylamines as PI3K inhibitors

‌

US Patent 11911388 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug

Patent Primary Examiner

‌

Mark L. Berch

Patent abstract

The present invention relates to new substituted xanthines of general formula

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7495002 3-methyl-7-butinyl-xanthines, the preparation thereof and their use as pharmaceutical compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API